Abstract：Sarcopenia is a progressive skeletal muscle disease characterized by a decline in muscle strength quantity quality and
function. It is commonly observed in elderly individuals cancer patients and those with chronic diseases. Sarcopenia significantly
increases the risk of falls surgical complications and mortality rates among high-risk populations imposing a substantial burden on
both healthcare systems and society. However there is currently no unified screening and diagnostic criteria for sarcopenia and there
is a lack of systematic and individualized diagnostic criteria and standardized treatment measures suitable for the Chinese
population. This article aims to summarize published research and guidelines related to sarcopenia to establish standardized screening
criteria diagnostic and treatment processes and systems with Chinese characteristics. These can be applied in healthcare institutions
at all levels in China for screening assessment diagnosis treatment and monitoring of sarcopenia providing a reference for clinical
practitioners and researchers.
上海市抗癌协会肿瘤营养与支持治疗专业委员会. 肌肉减少症规范化筛查、评估、诊断、治疗和监测技术标准[J]. 肿瘤代谢与营养电子杂志, 2024, 11(6): 782-787.
Shanghai Anticancer Association Oncology Nutrition and Supportive Therapy Professional Committee. Establishment of standardized screening diagnosis and treatment criteria for sarcopenia and expert recommendations. Electron J Metab Nutr Cancer, 2024, 11(6): 782-787.
